Alantra appoints a Managing Director in the U.S. to strengthen its global Healthcare practice

New York City, 16 May 2025 –  Alantra, the independent global mid-market financial services firm, has expanded its global Healthcare investment banking team with the appointment of Zeke Navar as Managing Director. Zeke brings extensive know-how in artificial intelligence and machine learning, behavioral health, value-based care enablement, payor and self-funded plans, healthcare financialization, revenue cycle management, pharma-IT, and personalized medicine, amongst others.

He is a seasoned investment banker with deep expertise across the healthcare ecosystem, spanning providers, patients, payors, and pharma. Prior to joining Alantra, he was Managing Director and Head of HealthTech at Union Square Advisors LLC. He has also held senior roles at Crosstree Capital Partners Inc., JMP Securities LLC, and H2C Securities Inc., where he led efforts in HCIT & Services and advised middle-market companies.

This strategic hire reflects Alantra’s continued investment in its U.S. presence and its commitment to growing scale across its core sectors: Consumer, Industrials, Healthcare, and Technology. The firm’s U.S. team is composed of approximately 50 bankers based in New York City and Boston.

Alantra’s global healthcare team advises across four key verticals: Consumer Health, Life Sciences, HealthTech, and MedTech. In the last two years, the team has completed 26 transactions worth over €2.4bn across the U.S., France, Germany, Switzerland, the UK, Spain, and the Nordics. Notable deals include Alantra advising Halloran Consulting Group on its sale to ProductLife Group, Oakley Capital on the strategic combination of Germany’s largest independent OTC and wellbeing platform Windstar Medical with Merz Group, and Wisconsin Pharmacal on the sale of vH essentials® to Avista-backed Wellspring Consumer Healthcare.